# The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

> **NCT06623370** · PHASE4 · COMPLETED · sponsor: **Konya City Hospital** · enrollment: 80 (actual)

## Conditions studied

- Sugammadex Reversal Time
- Muscle Weakness

## Interventions

- **DRUG:** methylprednisolone
- **OTHER:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT06623370
- **Lead sponsor:** Konya City Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-01-17
- **Final completion:** 2025-01-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623370, "The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06623370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*